文献速递安宁疗护

虚拟现实技术在临终患者症状管理中的效果:系统综述与荟萃分析

Effectiveness of Virtual Reality Technology in Symptom Management of Patients at the end of life: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Am Med Dir Assoc · 2024-06-13

本系统综述与荟萃分析纳入3项随机对照试验和6项类实验研究,共234例临终患者,评估虚拟现实(VR)技术对症状管理的效果。结果显示VR干预后疼痛、气短、抑郁和焦虑显著改善,但疲乏、嗜睡、恶心和食欲缺乏无显著差异。

要点

  • VR可显著改善临终患者的疼痛、气短、抑郁和焦虑。
  • 对疲乏、嗜睡、恶心和食欲缺乏,VR效果不显著,需进一步研究。
  • 证据来自3项RCT和6项类实验研究,共234例临终患者。

核心结论

  • VR技术可有效改善临终患者的疼痛、气短、抑郁和焦虑。
  • 对疲乏、嗜睡、恶心和食欲缺乏,VR效果不显著,需进一步研究。

研究设计与样本

  • 系统综述与荟萃分析,已在PROSPERO注册(CRD42022344679)。
  • 纳入3项随机对照试验和6项类实验研究,共234例临终患者。
  • 检索PubMed、Embase、Web of Science、Cochrane Library、JBI、EBSCO、CNKI、万方和SinoMed,从建库至2023年7月31日。

主要发现

  • 与VR干预前相比,疼痛显著改善(SMD -0.89,95% CI -1.29至-0.48,P < .05)。
  • 气短显著改善(MD -0.98,95% CI -0.98至0.51,P < .05)。
  • 抑郁显著改善(MD -0.62,95% CI -0.85至-0.40,P < .05)。
  • 焦虑显著改善(SMD -0.93,95% CI -1.50至0.36,P < .05)。
  • 疲乏、嗜睡、恶心和食欲缺乏未见显著差异。

临床怎么用

  • 可考虑将VR技术用于临终患者疼痛、气短、抑郁和焦虑的症状管理。
  • 对疲乏、嗜睡、恶心和食欲缺乏,暂不建议基于现有证据常规使用VR。

局限性

  • 纳入研究包括3项随机对照试验和6项类实验研究,证据等级有限。
  • 样本量较小,共234例临终患者。
  • 检索截至2023年7月31日,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this review was to explore the effectiveness of virtual reality (VR) technology in symptom management of patients at the end of life. DESIGN: This is a systematic review and meta-analysis, which has been registered on PROSPERO (CRD42022344679). SETTING AND PARTICIPANTS: Patients at the end of life. METHODS: PubMed, Embase, Web of Science, the Cochrane Library, JBI, EBSCO, CNKI, Wanfang, and SinoMed were searched from inception to July 31, 2023. Search terms included "virtual reality" and "end-of-life." Articles were screened according to the inclusion and exclusion criteria. The random effects model was used to calculate the standardized mean difference (SMD), and the fixed effects model was used to calculate the mean difference (MD). The Cochrane Risk of Bias Tool 2.0 and JBI Evaluation tool were used to assess the risk of bias. The I2 statistic was used to measure heterogeneity between studies. Forest plots were used for analysis. RESULTS: A total of 234 patients at the end of life from 3 randomized controlled trials and 6 quasi-experimental studies were included. Compared with pre-VR intervention, the pain [standardized mean difference (SMD) -0.89, 95% CI -1.29 to -0.48, P < .05], shortness of breath [mean difference (MD) -0.98, 95% CI -0.98-0.51, P < .05], depression (MD -0.62, 95% CI -0.85 to -0.40, P < .05), and anxiety (SMD -0.93, 95% CI -1.50 to 0.36, P < .05) of patients at the end of life was significantly improved after VR intervention. However, there were no significant differences observed in tiredness, drowsiness, nausea, and lack of appetite. CONCLUSIONS AND IMPLICATIONS: VR technology can be effective in improving pain, shortness of breath, depression, and anxiety in patients at the end of life. For tiredness, drowsiness, nausea, and lack of appetite, further research is required.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Xia W, Ding J, Yan Y, et al. Effectiveness of Virtual Reality Technology in Symptom Management of Patients at the end of life: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2024. PMID: 38880120. doi:10.1016/j.jamda.2024.105086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。